Literature DB >> 20047096

Blimp-1 is a tumor suppressor gene in lymphoid malignancies.

Akira Hangaishi1, Mineo Kurokawa.   

Abstract

B lymphocyte-induced maturation protein (Blimp-1) is a transcriptional factor, which controls the terminal differentiation of mature B cells to plasma cells. Blimp-1 is also called positive regulatory domain I-binding factor-1 (PRDI-BF1) or PR (PRDI-BF1-RIZ) domain zinc finger protein 1 (PRDM1). Furthermore, Blimp-1 is located in chromosome 6q21-22.1, a region frequently deleted in several tumors including lymphoid malignancies and has been supposed to be a candidate of tumor suppressor gene. Recently, mutational inactivation of Blimp-1 has been identified in a subset of diffuse large B-cell lymphomas of the activated B-cell type. In addition, an important role for Blimp-1 in maintaining the homeostasis of effector T cells is emerging and high expression of Blimp-1beta, a splicing variant of Blimp-1, have been presumed to be associated with poor prognosis in T cell lymphoma although this aspect of the gene needs further investigation. For this reason, we focused on the tumor suppressor function of Blimp-1 on not only B but also T cell malignancies in this review.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20047096     DOI: 10.1007/s12185-009-0472-5

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  38 in total

1.  Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas.

Authors:  Wayne Tam; Mario Gomez; Amy Chadburn; Joong W Lee; Wing C Chan; Daniel M Knowles
Journal:  Blood       Date:  2006-01-19       Impact factor: 22.113

2.  BLIMP-1: trigger for differentiation of myeloid lineage.

Authors:  D H Chang; C Angelin-Duclos; K Calame
Journal:  Nat Immunol       Date:  2000-08       Impact factor: 25.606

3.  Identification of a functionally impaired positive regulatory domain I binding factor 1 transcription repressor in myeloma cell lines.

Authors:  Ildikó Györy; György Fejér; Nilanjan Ghosh; Ed Seto; Kenneth L Wright
Journal:  J Immunol       Date:  2003-03-15       Impact factor: 5.422

4.  Transcriptional repression mediated by the PR domain zinc finger gene RIZ.

Authors:  M Xie; G Shao; I M Buyse; S Huang
Journal:  J Biol Chem       Date:  1997-10-17       Impact factor: 5.157

Review 5.  The biology of human lymphoid malignancies revealed by gene expression profiling.

Authors:  Louis M Staudt; Sandeep Dave
Journal:  Adv Immunol       Date:  2005       Impact factor: 3.543

6.  TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas.

Authors:  Keiichiro Honma; Shinobu Tsuzuki; Masao Nakagawa; Hiroyuki Tagawa; Shigeo Nakamura; Yasuo Morishima; Masao Seto
Journal:  Blood       Date:  2009-07-16       Impact factor: 22.113

7.  Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells.

Authors:  Kuo-I Lin; Cristina Angelin-Duclos; Tracy C Kuo; Kathryn Calame
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

8.  Frequent inactivation of A20 in B-cell lymphomas.

Authors:  Motohiro Kato; Masashi Sanada; Itaru Kato; Yasuharu Sato; Junko Takita; Kengo Takeuchi; Akira Niwa; Yuyan Chen; Kumi Nakazaki; Junko Nomoto; Yoshitaka Asakura; Satsuki Muto; Azusa Tamura; Mitsuru Iio; Yoshiki Akatsuka; Yasuhide Hayashi; Hiraku Mori; Takashi Igarashi; Mineo Kurokawa; Shigeru Chiba; Shigeo Mori; Yuichi Ishikawa; Koji Okamoto; Kensei Tobinai; Hitoshi Nakagama; Tatsutoshi Nakahata; Tadashi Yoshino; Yukio Kobayashi; Seishi Ogawa
Journal:  Nature       Date:  2009-05-03       Impact factor: 49.962

9.  Plasma cell ontogeny defined by quantitative changes in blimp-1 expression.

Authors:  Axel Kallies; Jhagvaral Hasbold; David M Tarlinton; Wendy Dietrich; Lynn M Corcoran; Philip D Hodgkin; Stephen L Nutt
Journal:  J Exp Med       Date:  2004-10-18       Impact factor: 14.307

10.  Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma.

Authors:  Laura Pasqualucci; Mara Compagno; Jane Houldsworth; Stefano Monti; Adina Grunn; Subhadra V Nandula; Jon C Aster; Vundavally V Murty; Margaret A Shipp; Riccardo Dalla-Favera
Journal:  J Exp Med       Date:  2006-02-20       Impact factor: 14.307

View more
  4 in total

1.  A step toward slaying the hydra of second cancers.

Authors:  Lindsay M Morton; Stephen J Chanock
Journal:  Nat Med       Date:  2011-08-04       Impact factor: 53.440

2.  Hypermethylation of the tumor suppressor gene PRDM1/Blimp-1 supports a pathogenetic role in EBV-positive Burkitt lymphoma.

Authors:  T Zhang; J Ma; K Nie; J Yan; Y Liu; C E Bacchi; E M Queiroga; G Gualco; J T Sample; A Orazi; D M Knowles; W Tam
Journal:  Blood Cancer J       Date:  2014-11-07       Impact factor: 11.037

3.  Fasting selectively blocks development of acute lymphoblastic leukemia via leptin-receptor upregulation.

Authors:  Zhigang Lu; Jingjing Xie; Guojin Wu; Jinhui Shen; Robert Collins; Weina Chen; Xunlei Kang; Min Luo; Yizhou Zou; Lily Jun-Shen Huang; James F Amatruda; Tamra Slone; Naomi Winick; Philipp E Scherer; Cheng Cheng Zhang
Journal:  Nat Med       Date:  2016-12-12       Impact factor: 53.440

4.  Differential epigenetic regulation between the alternative promoters, PRDM1α and PRDM1β, of the tumour suppressor gene PRDM1 in human multiple myeloma cells.

Authors:  Raquel Romero-García; Laura Gómez-Jaramillo; Rosa María Mateos; Gema Jiménez-Gómez; Nuria Pedreño-Horrillo; Esther Foncubierta; Juan Francisco Rodríguez-Gutiérrez; Sebastián Garzón; Francisco Mora-López; Carmen Rodríguez; Luis M Valor; Antonio Campos-Caro
Journal:  Sci Rep       Date:  2020-09-28       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.